Joel S. Marcus has served as Chairman of the Board of Directors since May 2007, Chief Executive Officer since March 1997, President since February 2009 and a director since the Company’s inception in 1994. Mr. Marcus was previously Vice Chairman and Chief Operating Officer from inception to his appointment as Chief Executive Officer. He was Secretary from inception to April 1997. From 1986 to 1994, Mr. Marcus was a partner at the law firm of Brobeck, Phleger & Harrison LLP (including a predecessor firm), specializing in corporate finance and capital markets, venture capital and mergers and acquisitions in the biopharmaceutical industry. From 1984 to 1994, he also served as outside General Counsel and Secretary of Kirin Amgen, Inc., a joint venture which financed the development of, and owned patents to, two multi billion dollar genetically engineered biopharmaceutical products. Mr. Marcus was formerly a practicing certified public accountant specializing in the acquisition, disposition, financing and taxation of real estate. He received his undergraduate and Juris Doctor degrees from the University of California at Los Angeles. He is a member of the National Association of Real Estate Investment Trusts (“NAREIT”) and is a member of the NAREIT’s Board of Governors. Mr. Marcus received the Ernst & Young 1999 Entrepreneur of the Year Award (Los Angeles—Real Estate). Mr. Marcus is on the Board of Directors for Private National Mortgage Acceptance (PennyMac), Boston Biomedical Inc. and Intracellular Therapies, Inc.